Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
CS Capital Co., Ltd. (承树投资) was founded in 2010 and is headquartered in Shanghai, China. The firm focuses on investments in the life sciences, consumer healthcare, and medical device industries, aiming to support the development of these sectors. CS Capital has established itself as a significant player in the Chinese investment landscape, leveraging its roots in private equity investment and financial advisory services.
Over the years, CS Capital has built a reputation for fostering long-term partnerships with entrepreneurs, emphasizing sustainable value creation through its investments. The firm has a diverse portfolio that includes companies in various stages of growth, particularly in healthcare and consumer sectors. As of now, CS Capital manages a portfolio of seven companies, showcasing its commitment to supporting innovative solutions in these industries.
CS Capital's office is located at 500 Pudong South Road, 16H, Shanghai, 200120. The firm is led by a team of experienced professionals with deep expertise in investment management and a strong understanding of the Chinese market.
CS Capital specializes in growth-stage investments, primarily targeting companies within the healthcare and consumer sectors. The firm seeks to identify businesses with significant growth potential in the early to mid-stages of development. Their investment strategy emphasizes long-term partnerships with entrepreneurs, aiming to create sustainable value through flexible capital solutions.
The sectors of focus include life sciences, consumer healthcare, and medical devices, with a particular interest in innovative solutions that drive progress in these areas. CS Capital is known for its ability to provide not just capital but also operational guidance and strategic insights to its portfolio companies. The firm actively collaborates with entrepreneurs to foster innovation and support the growth of their businesses.
CS Capital's portfolio includes a diverse range of companies, primarily in the healthcare and consumer sectors. Notable portfolio companies include:
This portfolio reflects CS Capital's commitment to supporting companies that are at the forefront of innovation in their respective fields.
楼民 (Min Lou): Chairman and Founding Partner. Min has extensive experience in investment banking and has played a pivotal role in establishing CS Capital as a leading investment firm in China.
吴映辉 (Yuan Sun): Senior Partner and Investment Committee Member. Yuan has a strong background in finance and investment, with a focus on healthcare and technology sectors.
鲁赛 (Lu Sai): Executive Director. Lu brings significant operational expertise and has been instrumental in managing portfolio companies.
何方元 (He Fangyuan): Executive Director. He has a wealth of experience in investment management and strategic planning.
黎孔霖 (Li Konglin): Investment Analyst. Li supports the investment team with market research and analysis.
陈丽华 (Chen Lihua): Operations Director. Chen oversees the operational aspects of the firm and ensures efficient management of portfolio companies.
顾冠 (Gu Guan): Partner and Investment Committee Member. Gu has a strong track record in venture capital and private equity investments.
To pitch CS Capital, founders should send an email to liminyue@cscapital.cn. A comprehensive pitch deck is essential, including details about the business model, market analysis, and team qualifications. While specific response times are not disclosed, founders should expect a thorough review process.
Warm introductions can be beneficial, as CS Capital values connections within the industry. Founders are encouraged to highlight any existing partnerships or endorsements from reputable sources in their pitches.
On September 29, 2024, NIO announced that CS Capital Co., Ltd. was one of three existing strategic investors committing new capital into NIO China as part of an aggregate RMB 3.3 billion strategic investment. This investment highlights CS Capital's active role in supporting innovative companies in the automotive sector.
Earlier, Neusoft reported that CS Capital led Neusoft Reach's RMB650 million first financing round, contributing RMB600 million. This involvement underscores CS Capital's commitment to advancing technology and innovation in the automotive software industry.
What are CS Capital's investment criteria?
CS Capital focuses on growth-stage investments in the healthcare and consumer sectors. They seek companies with significant growth potential and a strong management team.
How can I pitch to CS Capital?
Founders can reach out to CS Capital via email at liminyue@cscapital.cn. A well-prepared pitch deck that outlines the business model, market opportunity, and team is recommended.
What makes CS Capital different from other investors?
CS Capital emphasizes long-term partnerships with entrepreneurs, providing not just capital but also operational guidance and strategic insights to help companies grow.
What is CS Capital's geographic focus?
The firm primarily invests in companies based in Asia, with a strong emphasis on the Chinese market.
What is the typical check size for investments?
While specific check sizes are not disclosed, CS Capital focuses on growth-stage investments, which typically involve larger capital commitments to support scaling operations.
What is CS Capital's post-investment involvement like?
CS Capital actively engages with its portfolio companies, providing strategic support and leveraging its network to help drive growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.